期刊文献+

乳腺癌辅助内分泌治疗的不良反应及其中医药治疗探讨 被引量:12

Adverse reactions of adjuvant endocrine therapy for breast cancer and its traditional Chinese medicine treatment
下载PDF
导出
摘要 辅助内分泌治疗是目前国内外推荐的标准的激素受体阳性乳腺癌的辅助治疗手段。然长期使用内分泌药物治疗乳腺癌,将使患者产生激素减退相关的不良反应,降低患者内分泌治疗的依从性,影响乳腺癌的治疗效果。祖国传统中医药能从整体观出发,辨证论治已成为降低长期使用内分泌药物所引起的不良反应的重要治疗手段之一。本文将对临床常用的乳腺癌辅助内分泌药物所引起的相关不良反应作一总结,并从中医药角度概述其病因病机及治法方药。 Adjunctive endocrine therapy is the standard adjuvant treatment for hormone receptor-positive patients with breast cancer currently recommended at home and abroad. However, long-term use of endocrine drugs to treat breast cancer may cause adverse reactions related to hormone reduction, reduce the compliance of patients with endocrine therapy, and affect the therapeutic effect of breast cancer. Traditional Chinese medicine can treat the patients differentially from a holistic view, and has become one of the important treatments to reduce the adverse reactions caused by long-term use of endocrine drugs. This article will summarize the adverse reactions caused by adjuvant endocrine therapy for breast cancer and outline the pathogenesis and treatment from the perspective of Chinese medicine.
作者 陈晓霞 王彬彬 顾锡冬 CHEN Xiaoxia;WANG Binbin;GU Xidong(The First Clinical Medical College,Zhejiang Chinese Medical University,Hangzhou 310053,China)
出处 《中国现代医生》 2019年第4期157-160,共4页 China Modern Doctor
基金 浙江省医药卫生计划(2015KYB268)
关键词 乳腺癌 内分泌药物 不良反应 中医药治疗 Breast cancer Endocrine drugs Adverse reactions Chinese medicine treatment
  • 相关文献

参考文献13

二级参考文献197

共引文献1502

同被引文献119

引证文献12

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部